DITEX
Price
$12.55
Change
-$0.04 (-0.32%)
Updated
Jan 10 closing price
Net Assets
379.23M
VWIUX
Price
$13.50
Change
-$0.04 (-0.30%)
Updated
Jan 10 closing price
Net Assets
77.07B
Ad is loading...

DITEX vs VWIUX

Header iconDITEX vs VWIUX Comparison
Open Charts DITEX vs VWIUXBanner chart's image
BNY Mellon Intermediate Municipal Bond
Price$12.55
Change-$0.04 (-0.32%)
VolumeN/A
Net Assets379.23M
Vanguard Interm-Term Tx-Ex Adm
Price$13.50
Change-$0.04 (-0.30%)
VolumeN/A
Net Assets77.07B
DITEX vs VWIUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DITEX vs. VWIUX commentary
Jan 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DITEX is a Hold and VWIUX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VWIUX has more cash in the bank: 77.1B vs. DITEX (379M). VWIUX pays higher dividends than DITEX: VWIUX (2.88) vs DITEX (2.39). DITEX was incepted earlier than VWIUX: DITEX (41 years) vs VWIUX (24 years). VWIUX is a more actively managed with annual turnover of: 43.00 vs. DITEX (14.58). DITEX has a lower initial minimum investment than VWIUX: DITEX (2500) vs VWIUX (50000). DITEX annual gain was more profitable for investors over the last year : 0.73 vs. VWIUX (-1.68). DITEX return over 5 years is better than : 1.57 vs. VWIUX (-7.01).
DITEXVWIUXDITEX / VWIUX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years24 years-
Gain YTD-0.397-0.51677%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets379M77.1B0%
Annual Yield % from dividends2.392.8883%
Returns for 1 year0.73-1.68-44%
Returns for 3 years-1.30-7.2618%
Returns for 5 years1.57-7.01-22%
Returns for 10 years12.07-5.71-211%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTS0.45N/A
+0.81%
Abits Group
JWN24.01-0.08
-0.33%
Nordstrom
ARES175.04-7.26
-3.98%
Ares Management Corp
CRDF3.61-0.30
-7.55%
Cardiff Oncology
NTLA10.20-1.82
-15.14%
Intellia Therapeutics